📊 Score Breakdown
Offering Ability
20
Cash Runway
65
Float Risk
15
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
47%
🔄 Reverse Split
65%
• 50-day avg $0.03 below $1 exchange minimum
• 10 months cash with weak price
📉 Score Deterioration
40%
• Score rose 15 points recently (worsening)
💰 Capital Raise
15%
• Under 12 months cash (10mo)
💹 Market Data
Market Cap$39.87M
Shares Outstanding1.85B
Float1.32B
Cash$5.56M
Debt$3.69M
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest84.8K
Days to Cover1.0
% of Float0.0%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2026
xbrl
XBRL CONVERTIBLE
Mar 31, 2020
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for INVU
📊 INVU FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 INVU Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.